• +1 (416) 597-3422 ext.7800
  • kite@uhn.ca

Krista L. Lanctôt

Dr. Krista Lanctôt leads a large interdisciplinary research team whose goal is to optimize treatment for neuropsychiatric symptoms including cognitive changes, apathy, agitation, and mood changes. The research team also focuses on understanding how these neuropsychiatric symptoms may interfere with cardiac rehabilitation. Her research addresses these goals by determining the underlying neurobiology of neuropsychiatric symptoms, examining predictors of treatment response, and using novel or repurposed pharmacological treatments. The research team has also investigated exercise and dietary interventions in the cardiac rehabilitation population. A variety of tools including neuroimaging, lipidomics, serum biomarkers, and neuropsychiatric assessments are used in combination with pharmacotherapeutic trials. This research will contribute to our understanding of the link between neurotransmitter dysfunction, proteins, lipids and metabolites and neuropsychiatric symptoms. 

Contact Me

  • Affiliate Scientist, KITE (TRI)
  • Senior scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute
  • Professor, Departments of Psychiatry, and Pharmacology and Toxicology, University of Toronto
  • Vice Chair, Basic and Clinical Sciences, Department of Psychiatry, University of Toronto
  • Executive director, MORE research group
  • Full Member, School of Graduate Studies, University of Toronto
  • Neuropsychiatric symptoms secondary to central nervous system pathology
  • Neuroimaging, serum protein, lipid and metabolite biomarkers
  • Medical, dietary and exercise interventions